Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
3,283,246
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
197,515
-
Shares change
-
+81,174
-
Total reported value, excl. options
-
$491,813
-
Value change
-
+$202,123
-
Number of buys
-
6
-
Number of sells
-
1
-
Price
-
$2.49
Institutional Holders of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) as of Q3 2024
As of 30 Sep 2024 AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 197,515 shares of stock of the company.
Largest 8 holders included ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Moss Adams Wealth Advisors LLC, UBS Group AG, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This table shows 8 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.